• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在接受主动脉瓣置换术的患者中,使用含和不含普鲁卡因的晶体心脏停搏液对心肌进行超微结构研究。

Ultrastructural study of the myocardium using cardioplegic crystalloid solution with and without procaine in patients undergoing aortic valve replacement.

作者信息

Dussin Luiz Henrique, Moura Leandro de, Gib Marcelo Curcio, Saadi Eduardo Keller, Barbosa Gilberto Venossi, Wender Orlando Carlos Belmonte

机构信息

Hospital de Clínicas de Porto Alegre, UFRGS.

出版信息

Rev Bras Cir Cardiovasc. 2008 Jul-Sep;23(3):389-95. doi: 10.1590/s0102-76382008000300017.

DOI:10.1590/s0102-76382008000300017
PMID:19082329
Abstract

OBJECTIVE

The aim of this study was to assess whether the presence of procaine in crystalloid cardioplegic solution increases myocardial protection at the ultra structural level.

METHODS

Eighteen patients that underwent aortic valve replacement in the Hospital de Clínicas de Porto Alegre over a 10-month period were studied. They were randomly allocated into two groups: group A--eight patients receiving cardioplegia without procaine; group B--ten patients receiving cardioplegia with procaine. Myocardial biopsies were performed in three different periods: 1st--before ischemic arrest, 2nd--at the end of ischemic arrest, and 3rd--15 minutes after reperfusion.

RESULTS

The ultra structural analysis comparing the groups in the three moments did not show any statistically significant difference. The mean score in group A at moment I, II and III was 0.1 +/- 0.2; 0.4 +/- 0.3; 0.4 +/- 0.4, and group B 0.2 +/- 0.2; 0.4 +/- 0.3; 0.7 +/- 0.2. Comparative analysis of CK-MB was similar. The spontaneous return to sinus rhythm after aortic declamping in group B occurred in 70% and in group A 12.5% (p=0.024).

CONCLUSION

Both cardioplegic solutions tested were equally effective in myocardial preservation, and we could not demonstrate at the ultrastructural level any benefit when procaine was added. The spontaneous return to sinus rhythm after aortic declamping was significantly greater when procaine was added.

摘要

目的

本研究旨在评估晶体心脏停搏液中加入普鲁卡因是否能在超微结构水平上增强心肌保护作用。

方法

对在阿雷格里港临床医院10个月期间接受主动脉瓣置换术的18例患者进行研究。他们被随机分为两组:A组——8例患者接受不含普鲁卡因的心脏停搏液;B组——10例患者接受含普鲁卡因的心脏停搏液。在三个不同时期进行心肌活检:第1期——缺血停搏前,第2期——缺血停搏结束时,第3期——再灌注后15分钟。

结果

在三个时间点对两组进行的超微结构分析未显示任何统计学上的显著差异。A组在第I、II和III期的平均评分为0.1±0.2;0.4±0.3;0.4±0.4,B组为0.2±0.2;0.4±0.3;0.7±0.2。CK-MB的比较分析结果相似。B组主动脉钳夹松开后窦性心律自动恢复的发生率为70%,A组为12.5%(p = 0.024)。

结论

所测试的两种心脏停搏液在心肌保护方面同样有效,并且我们在超微结构水平上未证实加入普鲁卡因有任何益处。加入普鲁卡因后主动脉钳夹松开后窦性心律自动恢复的情况明显更好。

相似文献

1
Ultrastructural study of the myocardium using cardioplegic crystalloid solution with and without procaine in patients undergoing aortic valve replacement.在接受主动脉瓣置换术的患者中,使用含和不含普鲁卡因的晶体心脏停搏液对心肌进行超微结构研究。
Rev Bras Cir Cardiovasc. 2008 Jul-Sep;23(3):389-95. doi: 10.1590/s0102-76382008000300017.
2
Cold blood cardioplegia reduces the increase in cardiac enzyme levels compared with cold crystalloid cardioplegia in patients undergoing aortic valve replacement for isolated aortic stenosis.在因单纯主动脉瓣狭窄接受主动脉瓣置换术的患者中,冷血停搏液与冷血晶体停搏液相比,可降低心肌酶水平的升高。
J Thorac Cardiovasc Surg. 2010 Apr;139(4):874-80. doi: 10.1016/j.jtcvs.2009.05.036. Epub 2009 Jul 26.
3
Comparative experimental study of myocardial protection with crystalloid solutions for heart transplantation.心脏移植中晶体溶液心肌保护的比较实验研究
Rev Bras Cir Cardiovasc. 2012 Jan-Mar;27(1):110-6. doi: 10.5935/1678-9741.20120016.
4
Effects of myocardial protection in hypertrophic rabbit hearts: structural and ultra structural analysis.肥厚型兔心脏中心肌保护的作用:结构和超微结构分析
Rev Bras Cir Cardiovasc. 2007 Jan-Mar;22(1):24-32. doi: 10.1590/s0102-76382007000100008.
5
A clinical comparative study between crystalloid and blood-based St Thomas' hospital cardioplegic solution.晶体与基于血液的圣托马斯医院心脏停搏液的临床对比研究。
Eur J Cardiothorac Surg. 1999 Jan;15(1):75-83. doi: 10.1016/s1010-7940(98)00287-5.
6
Cold blood versus cold crystalloid cardioplegia: a prospective randomised study of 345 aortic valve patients.冷血与冷血晶体停搏液:345 例主动脉瓣患者的前瞻性随机研究。
Eur J Cardiothorac Surg. 2010 Dec;38(6):745-9. doi: 10.1016/j.ejcts.2010.03.052. Epub 2010 May 7.
7
Cardioprotection by sevoflurane against reperfusion injury after cardioplegic arrest in the rat is independent of three types of cardioplegia.七氟醚对大鼠心脏停搏后再灌注损伤的心脏保护作用与三种类型的心脏停搏液无关。
Br J Anaesth. 2002 Jun;88(6):828-35. doi: 10.1093/bja/88.6.828.
8
Early changes in regional and global left ventricular function after aortic valve replacement. Comparison of crystalloid, cold blood, and warm blood cardioplegias.
Circulation. 1995 Nov 1;92(9 Suppl):II155-62. doi: 10.1161/01.cir.92.9.155.
9
A generalized consideration of myocardial preservation with cold crystalloid versus warm blood cardioplegia in heart valve replacement.心脏瓣膜置换术中冷晶体停搏液与温血停搏液心肌保护的综合考量
Kaohsiung J Med Sci. 1998 May;14(5):266-73.
10
Leukocyte-depleted terminal blood cardioplegia provides superior myocardial protective effects in association with myocardium-derived nitric oxide and peroxynitrite production for patients undergoing prolonged aortic crossclamping for more than 120 minutes.对于接受超过120分钟长时间主动脉阻断的患者,去白细胞终末血液停搏液与心肌源性一氧化氮和过氧亚硝酸盐的产生相关联,具有卓越的心肌保护作用。
J Thorac Cardiovasc Surg. 2003 Dec;126(6):1813-21. doi: 10.1016/s0022-5223(03)01282-0.

引用本文的文献

1
Single-Dose Lignocaine-Based Blood Cardioplegia in Single Valve Replacement Patients.单剂量利多卡因血停搏液在单瓣膜置换患者中的应用
Braz J Cardiovasc Surg. 2017 Mar-Apr;32(2):90-95. doi: 10.21470/1678-9741-2016-0025.
2
Cardioplegic strategies to protect the hypertrophic heart during cardiac surgery.心脏手术期间保护肥厚心脏的心脏停搏策略。
Perfusion. 2011 Sep;26 Suppl 1(Suppl 1):48-56. doi: 10.1177/0267659111420607.